media Media
Press Releases2020-05-07T14:51:44+00:00

Press Releases

Takeda’s Entyvio and Janssen’s Stelara Share of Inflammatory Bowel Disease Biologic-Naive Patients Continues to Increase as This Patient Group Expands Their Involvement in the Decision-Making Process

A newly published report by Spherix Global Insights includes the responses of 218 gastroenterologists and 1,001 audited patient records and reveals the current treatment approach for new start ulcerative colitis and Crohn’s disease patients  EXTON, Pa., July 30, 2020 /PRNewswire/ — The 2020 audit included in Spherix’s RealWorld Dynamix™: Biologic/Small Molecule New Starts in IBD (US) service focuses on a key bellwether of the ulcerative colitis and Crohn’s disease markets – the newly initiated patient. Despite the entry of only one [...]

July 30, 2020|

Alternate Mechanism Biologics and Adalimumab Biosimilar Prescribing Increases at the Expense of AbbVie’s Humira in the EU5 Inflammatory Bowel Disease Market, Despite the Significant Impact of COVID-19 on Gastroenterology Practitioners

Use of alternative mechanism of action therapies, Janssen’s Stelara and Takeda’s Entyvio, along with adalimumab biosimilars, has increased in the EU5 since last year in ulcerative colitis and Crohn’s disease, according to a recently published study by Spherix Global Insights  EXTON, Pa., July 20, 2020 /PRNewswire/ — According to the latest report published as part of Spherix’s RealTime Dynamix™: Inflammatory Bowel Disease (EU) service, EU5 gastroenterologists (n=255) report notable gains in their prescribing of alternative mechanism of action (AMOA) agents, such [...]

July 20, 2020|

Treatment of Anemia Among Hematology/Oncology Specialists Spans Diverse Patient Types, Many of Which Have Multiple Contributory Factors

According to Spherix Global Insights, the potential approval of the hypoxia-inducible factors prolyl-hydroxylase inhibitors could alter referral and treatment patterns for patients with anemia of chronic kidney disease being managed by hematologists/oncologists. EXTON, Pa., July 14, 2020 / PRNewswire / – Spherix recently fielded a survey of 152 hematologists/oncologists in the US in order to assess the current and future treatment paradigms of anemia patients treated by this specialist population. According to the Market Dynamix™ survey, anemia is a [...]

July 14, 2020|

COVID-19 Continues to Disrupt Patient Care Among Specialty Physicians, Though There Are Early Signs That Recovery is on the Horizon

According to Spherix Global Insights, just one-tenth of specialty physician offices are operating at normal capacity, and doctors report facing multiple challenges with re-opening EXTON, Pa., July 6, 2020 / PRNewswire / – Results from the seventh wave of an ongoing study examining the impact of COVID-19 on specialty physician practices were released last week and offer a glimmer of optimism about the path forward. In all, 257 dermatologists, gastroenterologists, nephrologists, neurologists, and rheumatologists provided feedback about the impact [...]

July 6, 2020|

Massive Shift in Practice Patterns in Psoriatic Arthritis as Rheumatologists Lean Toward Increased Use of JAK inhibitors and Novel Biologics

Spherix Global Insights releases fifth annual patient chart study focused exclusively on biologic and small molecule switching patterns among US rheumatologists EXTON, Pa., July 2, 2020 /PRNewswire/ – Over the past four years, multiple new agents have been FDA approved for the treatment of psoriatic arthritis (PsA), including Pfizer’s Xeljanz, Eli Lilly’s Taltz, BMS’ Orencia, and Janssen’s Simponi Aria. In addition, the development pipeline is ripe with many new agents offering novel mechanism approaches, including UCB’s bimekizumab and BMS’ [...]

July 2, 2020|
Go to Top